Serial 79230374
Live / Registered — Cancelled — Section 71 (as of 15 Aug 2025)
What this means for you
Registered since 29 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79230374
- Registration number
- 5663613
- Mark type
- Design / logo
- Filed
- 30 Mar 2017
- Published for opposition
- 13 Nov 2018
- Registered
- 29 Jan 2019
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical antitussive-cold preparations, preparations for treating colds and flu, preparations for preventing colds and flu, preparations for relief of cold and flu symptoms such as nasal congestion, cough and fever, and preparations for shortening the durations of colds and flu; sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical use and veterinary use; food for babies; dietary supplements for humans and animals; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, and adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infectious diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, and adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, and espiratory viruses; drugs for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based drugs pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; Pharmaceutical preparations, namely, immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infectious diseases
Owner
- Mapix S.à.r.l., LU
- Mapix S.à.r.l., LU
- Mapix S.à.r.l., LU
Prosecution history
- 15 Aug 2025 — CANCELLED SECTION 71
- 29 Jan 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 07 Jun 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 May 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 May 2019 — FINAL DISPOSITION PROCESSED
- 29 Apr 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 29 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Nov 2018 — PUBLISHED FOR OPPOSITION
- 09 Nov 2018 — NOTIFICATION PROCESSED BY IB
- 24 Oct 2018 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 24 Oct 2018 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 24 Oct 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Sept 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Sept 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED